Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJJ Scheres… - Cochrane Database …, 2020 - cochranelibrary.com
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent
antiphospholipid antibodies and recurrent pregnancy loss - Hamulyák, EN - 2020 | Cochrane …
antiphospholipid antibodies and recurrent pregnancy loss - Hamulyák, EN - 2020 | Cochrane …
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
EN Hamulyák, LJ Scheres, MC Marijnen… - The Cochrane …, 2020 - europepmc.org
Background Aspirin and heparin are widely used as preventive strategy to reduce the high
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJ Scheres… - The Cochrane …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Aspirin and heparin are widely used as preventive strategy to reduce the high
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJJ Scheres… - Cochrane …, 2020 - researchinformation.amsterdamumc …
Background: Aspirin and heparin are widely used as preventive strategy to reduce the high
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
[HTML][HTML] Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJJ Scheres, MC Marijnen… - The Cochrane …, 2020 - ncbi.nlm.nih.gov
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent
antiphospholipid antibodies and recurrent pregnancy loss - PMC Back to Top Skip to main …
antiphospholipid antibodies and recurrent pregnancy loss - PMC Back to Top Skip to main …
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJJ Scheres… - Cochrane Database …, 2020 - cochranelibrary.com
Objectifs Évaluer les effets de l'aspirine ou de l'héparine, ou des deux, sur l'amélioration de
l'issue des grossesses chez les femmes présentant des AAPL persistants (à deux dosages …
l'issue des grossesses chez les femmes présentant des AAPL persistants (à deux dosages …
[PDF][PDF] Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJJ Scheres, MC Marijnen… - status and date: New …, 2020 - vrt-edu.ru
Background Aspirin and heparin are widely used as preventive strategy to reduce the high
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
EN Hamulyák, LJ Scheres, MC Marijnen… - The Cochrane …, 2020 - europepmc.org
Background Aspirin and heparin are widely used as preventive strategy to reduce the high
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
[PDF][PDF] Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
EN Hamulyák, LJJ Scheres, MC Marijnen… - status and date: New …, 2020 - vrt-edu.ru
Background Aspirin and heparin are widely used as preventive strategy to reduce the high
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …
risk of recurrent pregnancy loss in women with antiphospholipid antibodies (aPL). This …